Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group
- Status
- WITHDRAWN
- Phase
- N/A
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase III B in Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- NA
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
CART-19 Cells For MRD Positive CD19+ ALL
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Home-exercise Program for Children and Adolescent Survivors of Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
- Status
- COMPLETED
- Phase
- PHASE1
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Thiopurine EnhAnced Maintenance Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
- Status
- COMPLETED
- Phase
- PHASE1
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
- Status
- COMPLETED
- Phase
- PHASE3